Trial Profile
Phase III trial of sinapultide [Surfaxin] compared to Curosurf in premature infants with respiratory distress syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs Sinapultide (Primary) ; Poractant alfa
- Indications Respiratory distress syndrome
- Focus Therapeutic Use
- Acronyms STAR
- Sponsors Discovery Laboratories
- 16 Apr 2015 New trial record